Vishwakarma A, Nasrin T, Hoque M, Ali S
Curr Microbiol. 2025; 82(5):191.
PMID: 40080168
DOI: 10.1007/s00284-025-04177-2.
Tomochi H, Mekaru Y, Murota K, Konishi M, Ikeda R, Yanase T
Arch Virol. 2025; 170(2):44.
PMID: 39893347
DOI: 10.1007/s00705-025-06233-5.
Kasongamulilo C, Syakalima M, Saasa N, Kainga H, Pandey G, Mukubesa A
PLoS One. 2025; 20(1):e0309288.
PMID: 39854363
PMC: 11760628.
DOI: 10.1371/journal.pone.0309288.
Li Z, Duan S, Yu T, Li B, Zhang W, Zhou C
Autophagy. 2024; 20(10):2133-2145.
PMID: 38762760
PMC: 11423686.
DOI: 10.1080/15548627.2024.2356505.
Fang Y, Wang J, Sun J, Su Z, Chen S, Xiao J
Virol Sin. 2024; 39(4):537-545.
PMID: 38679334
PMC: 11401450.
DOI: 10.1016/j.virs.2024.04.006.
Non-Structural Protein-W61 as a Novel Target in Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV): An In-Vitro and In-Silico Study on Protein-Protein Interactions with Nucleoprotein and Viral Replication.
Park J, Sivasankar C, Kirthika P, Prabhu D, Lee J
Viruses. 2023; 15(9).
PMID: 37766369
PMC: 10535573.
DOI: 10.3390/v15091963.
Novel Echarate Virus Variant Isolated from Patient with Febrile Illness, Chanchamayo, Peru.
Troncos G, Popuche D, Adhikari B, Long K, Rios J, Valerio M
Emerg Infect Dis. 2023; 29(9):1908-1912.
PMID: 37610254
PMC: 10461681.
DOI: 10.3201/eid2909.230374.
The La Crosse virus class II fusion glycoprotein loop contributes to infectivity and replication and .
Thannickal S, Spector S, Stapleford K
J Virol. 2023; 97(8):e0081923.
PMID: 37578236
PMC: 10506486.
DOI: 10.1128/jvi.00819-23.
Comparison of Immunogenicity Between a Candidate Live Attenuated Vaccine and an Inactivated Vaccine for Cache Valley Virus.
Ayers V, Huang Y, Kohl A, Dunlop J, Hettenbach S, Park S
Viral Immunol. 2023; 36(1):41-47.
PMID: 36622942
PMC: 9885547.
DOI: 10.1089/vim.2022.0103.
and Cache Valley virus: a new threat for virus transmission in New York State.
Dieme C, Maffei J, Diarra M, Koetzner C, Kuo L, Ngo K
Emerg Microbes Infect. 2022; 11(1):741-748.
PMID: 35179429
PMC: 8903793.
DOI: 10.1080/22221751.2022.2044733.
Structure of Rift Valley Fever Virus RNA-Dependent RNA Polymerase.
Wang X, Hu C, Ye W, Wang J, Dong X, Xu J
J Virol. 2021; 96(3):e0171321.
PMID: 34787453
PMC: 8826900.
DOI: 10.1128/JVI.01713-21.
NSs of the mildly virulent sandfly fever Sicilian virus is unable to inhibit interferon signaling and upregulation of interferon-stimulated genes.
Wuerth J, Weber F
J Gen Virol. 2021; 102(11).
PMID: 34726591
PMC: 8742993.
DOI: 10.1099/jgv.0.001676.
Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.
Lerolle S, Freitas N, Cosset F, Legros V
Viruses. 2021; 13(5).
PMID: 33925004
PMC: 8146327.
DOI: 10.3390/v13050784.
Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus.
Schoen A, Lau S, Verbruggen P, Weber F
J Virol. 2020; 94(7).
PMID: 31941775
PMC: 7081911.
DOI: 10.1128/JVI.02134-19.
Evolutionary Dynamics of Oropouche Virus in South America.
Gutierrez B, Wise E, Pullan S, Logue C, Bowden T, Escalera-Zamudio M
J Virol. 2019; 94(5).
PMID: 31801869
PMC: 7022353.
DOI: 10.1128/JVI.01127-19.
Evaluation of Portal Vein Doppler Findings in Patients with Crimean⁻Congo Hemorrhagic Fever.
Karavas E, Karakecili F
Medicina (Kaunas). 2019; 55(5).
PMID: 31100950
PMC: 6572247.
DOI: 10.3390/medicina55050146.
Structural and functional similarities in bunyaviruses: Perspectives for pan-bunya antivirals.
Ter Horst S, Conceicao-Neto N, Neyts J, Rocha-Pereira J
Rev Med Virol. 2019; 29(3):e2039.
PMID: 30746831
PMC: 7169261.
DOI: 10.1002/rmv.2039.
Development of reverse genetics systems and investigation of host response antagonism and reassortment potential for Cache Valley and Kairi viruses, two emerging orthobunyaviruses of the Americas.
Dunlop J, Szemiel A, Navarro A, Wilkie G, Tong L, Modha S
PLoS Negl Trop Dis. 2018; 12(10):e0006884.
PMID: 30372452
PMC: 6245839.
DOI: 10.1371/journal.pntd.0006884.
From dengue to Zika: the wide spread of mosquito-borne arboviruses.
Sukhralia S, Verma M, Gopirajan S, Dhanaraj P, Lal R, Mehla N
Eur J Clin Microbiol Infect Dis. 2018; 38(1):3-14.
PMID: 30267170
DOI: 10.1007/s10096-018-3375-7.
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20.
Feng J, Wickenhagen A, Turnbull M, Rezelj V, Kreher F, Tilston-Lunel N
J Virol. 2018; 92(13).
PMID: 29695422
PMC: 6002717.
DOI: 10.1128/JVI.02140-17.